(Updated - March 11, 2024 8:48 AM EDT)

Baird analyst Joel Beatty downgraded Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE